Current Cancer Drug Targets

Ruiwen Zhang 
Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106
USA

Back

EDITORIAL [Hot topic: RAS - A Central Feature in Cancer Targeted Therapy (Guest Editor: Balazs Gyorffy) promotion: free to download

Volume:10   Issue:8
Pp: 797-798
Balazs Gyorffy
DOI: 10.2174/156800910793358023

Order Reprints Order Eprints

Strategies for Overcoming Inherent and Acquired Resistance to EGFR Inhibitors by Targeting Downstream Effectors in the RAS/PI3K Pathway open access plus

Volume:10   Issue:8
Pp: 824-833
A. J. Weickhardt, N. C. Tebbutt and J. M. Mariadason
DOI: 10.2174/156800910793357961

Order Reprints Order Eprints

EDITORIAL [Hot topic: New Therapeutic Advances and Perspectives in Tumour Angiogenesis (Guest Editor: Eddy Pasquier)] promotion: free to download

Volume:10   Issue:8
Pp: 877-878
Eddy Pasquier and Nicolas Andre
DOI: 10.2174/156800910793358032

Order Reprints Order Eprints

Anti-Angiogenic Therapies for Children with Cancer

Volume:10   Issue:8
Pp: 879-889
N. Andre, A. Verschuur, J. Rossler and J. Sterba
DOI: 10.2174/156800910793357899

Order Reprints Order Eprints

Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by siRNA Sensitizes Tumor Cells to Complement Attack In Vitro

Volume:10   Issue:8
Pp: 922-931
N. Geis, S. Zell, R. Rutz, W. Li, T. Giese, S. Mamidi, S. Schultz and M. Kirschfink
DOI: 10.2174/156800910793357952

Order Reprints Order Eprints

Tumor-Targeted Inhibition by a Novel Strategy - Mimoretrovirus Expressing siRNA Targeting the Pokemon Gene

Volume:10   Issue:8
Pp: 932-941
Z. Tian, H. Wang, Z. Jia, J. Shi, J. Tang, L. Mao, H. Liu, Y. Deng, Y. He, Z. Ruan, J. Li, Y. Wu and B. Ni
DOI: 10.2174/156800910793357907

Order Reprints Order Eprints